The global Estrogen Blockers market is estimated to be valued at US$ 15.02 billion in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Estrogen blockers, also known as estrogen antagonists or antiestrogens, are pharmaceutical drugs that inhibit or block the action of estrogen in the body. These drugs are commonly used to treat hormone ... Read more

The global Estrogen Blockers Market is estimated to be valued at US$ 15.02 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Estrogen blockers are also known as anti-estrogens that help lower the level of estrogen in the body by binding to estrogen receptors and blocking the binding and action of estrogen. They are used to treat ... Read more

The estrogen blockers market comprises pharmaceutical products that are used to treat conditions caused by excess estrogen levels in the body. Estrogen blockers, also known as anti-estrogens, work by blocking the effects of estrogen on tissues and organs. Some common medical uses of estrogen blockers include treatment of breast cancer, endometriosis, fibrocystic breast disease, and estrogen-sensitive tumors. Key estrogen blocker drugs available commercially are tamoxifen, toremifene, and ... Read more